Stigmastane-3,6-diol

Details

Top
Internal ID f486df3e-6a8a-4e7e-ac0b-091f3a1412ff
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Stigmastanes and derivatives
IUPAC Name (3S,5S,6S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol
SMILES (Canonical) CCC(CCC(C)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C)C(C)C
SMILES (Isomeric) CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4)O)C)O)C)C(C)C
InChI InChI=1S/C29H52O2/c1-7-20(18(2)3)9-8-19(4)23-10-11-24-22-17-27(31)26-16-21(30)12-14-29(26,6)25(22)13-15-28(23,24)5/h18-27,30-31H,7-17H2,1-6H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,28-,29-/m1/s1
InChI Key FFLGORGANMRISQ-SJSKENPGSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C29H52O2
Molecular Weight 432.70 g/mol
Exact Mass 432.396730897 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 8.80
Atomic LogP (AlogP) 7.08
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 6

Synonyms

Top
112244-29-8
5alpha-Stigmast-3beta,6alpha-diol
6-Hydroxysitostanol
5alpha-stigmastane-3beta,6alpha-diol
24R-Ethyl-5a-cholestan-3ss,6a-diol

2D Structure

Top
2D Structure of Stigmastane-3,6-diol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 - 0.6228 62.28%
Blood Brain Barrier + 0.7500 75.00%
Human oral bioavailability + 0.6714 67.14%
Subcellular localzation Mitochondria 0.4862 48.62%
OATP2B1 inhibitior - 0.5797 57.97%
OATP1B1 inhibitior + 0.8247 82.47%
OATP1B3 inhibitior + 0.9706 97.06%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7750 77.50%
BSEP inhibitior - 0.5928 59.28%
P-glycoprotein inhibitior - 0.6207 62.07%
P-glycoprotein substrate + 0.5999 59.99%
CYP3A4 substrate + 0.7064 70.64%
CYP2C9 substrate - 0.6165 61.65%
CYP2D6 substrate + 0.3527 35.27%
CYP3A4 inhibition - 0.8415 84.15%
CYP2C9 inhibition - 0.8780 87.80%
CYP2C19 inhibition - 0.8451 84.51%
CYP2D6 inhibition - 0.9531 95.31%
CYP1A2 inhibition - 0.6507 65.07%
CYP2C8 inhibition - 0.7902 79.02%
CYP inhibitory promiscuity - 0.6683 66.83%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.8600 86.00%
Carcinogenicity (trinary) Non-required 0.6780 67.80%
Eye corrosion - 0.9848 98.48%
Eye irritation - 0.8917 89.17%
Skin irritation - 0.5616 56.16%
Skin corrosion - 0.9416 94.16%
Ames mutagenesis - 0.7678 76.78%
Human Ether-a-go-go-Related Gene inhibition - 0.6487 64.87%
Micronuclear - 0.9900 99.00%
Hepatotoxicity - 0.5230 52.30%
skin sensitisation + 0.5280 52.80%
Respiratory toxicity + 0.8222 82.22%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.8750 87.50%
Nephrotoxicity - 0.8545 85.45%
Acute Oral Toxicity (c) III 0.7341 73.41%
Estrogen receptor binding + 0.7346 73.46%
Androgen receptor binding + 0.7565 75.65%
Thyroid receptor binding + 0.6044 60.44%
Glucocorticoid receptor binding + 0.7392 73.92%
Aromatase binding + 0.5336 53.36%
PPAR gamma - 0.4948 49.48%
Honey bee toxicity - 0.7850 78.50%
Biodegradation - 0.8500 85.00%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity + 0.9699 96.99%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 96.00% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.50% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 93.86% 94.45%
CHEMBL221 P23219 Cyclooxygenase-1 92.49% 90.17%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.03% 97.09%
CHEMBL226 P30542 Adenosine A1 receptor 90.33% 95.93%
CHEMBL238 Q01959 Dopamine transporter 89.40% 95.88%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 88.69% 82.69%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 87.72% 95.89%
CHEMBL2581 P07339 Cathepsin D 87.18% 98.95%
CHEMBL1994 P08235 Mineralocorticoid receptor 86.79% 100.00%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 86.63% 95.58%
CHEMBL4685 P14902 Indoleamine 2,3-dioxygenase 83.59% 96.38%
CHEMBL268 P43235 Cathepsin K 83.43% 96.85%
CHEMBL242 Q92731 Estrogen receptor beta 83.27% 98.35%
CHEMBL4227 P25090 Lipoxin A4 receptor 83.04% 100.00%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.70% 90.71%
CHEMBL2179 P04062 Beta-glucocerebrosidase 82.46% 85.31%
CHEMBL1871 P10275 Androgen Receptor 82.19% 96.43%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 81.86% 92.88%
CHEMBL237 P41145 Kappa opioid receptor 81.80% 98.10%
CHEMBL2842 P42345 Serine/threonine-protein kinase mTOR 81.60% 92.78%
CHEMBL225 P28335 Serotonin 2c (5-HT2c) receptor 81.15% 89.62%
CHEMBL2996 Q05655 Protein kinase C delta 81.06% 97.79%
CHEMBL2413 P32246 C-C chemokine receptor type 1 80.87% 89.50%
CHEMBL3359 P21462 Formyl peptide receptor 1 80.73% 93.56%
CHEMBL5608 Q16288 NT-3 growth factor receptor 80.67% 95.89%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 80.28% 89.05%
CHEMBL218 P21554 Cannabinoid CB1 receptor 80.27% 96.61%

Cross-Links

Top
PubChem 12070151
NPASS NPC169392
LOTUS LTS0215026
wikiData Q104994526